Mylan Inc. (NASDAQ:MYL) slid 0.14%
to $21.17. Mylan Inc. is a global pharmaceutical company that develops,
licenses, manufactures, markets and distributes generic and branded generic
pharmaceuticals, specialty pharmaceuticals and active pharmaceutical
ingredients (APIs).
The stock has average daily volume of 8.32 million shares. At today`s
closing market price, the market capitalization of the company stands at $9.21 billion.
Cephalon, Inc. (NASDAQ:CEPH) fell 0.81%
to $62.16. The stock opened at $62.50 and was trading within the range of $61.49-$62.66.
Cephalon, Inc. is an international biopharmaceutical company
engaged in the discovery, development and commercialization of products in four
core therapeutic areas: central nervous system (CNS), pain, oncology and
inflammatory disease.
Human Genome Sciences (NASDAQ:HGSI) went down
1.55% to $24.20. The stock has a 52-week range of $20.56-$34.49.
The stock has average daily volume of 3.79 million shares. At today`s
closing market price, the market capitalization of the company stands at $4.57 billion.
Dendreon Corporation (NASDAQ:DNDN) lost 0.81% to $35.41 . Over the past three months of trading sessions, the stock slumped more than 14% and plunged more than 35% year-to-date.
Article published by Wall Street Grand. Visit the Wall Street Grand Club today.
For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
